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Abstract  15 
Pyrethroid resistance is widespread in the malaria vector Anopheles gambiae leading 16 
to concerns about the future efficacy of bednets with pyrethroids as the sole active 17 
ingredient. The incorporation of pyriproxyfen (PPF), a juvenile hormone analogue, into 18 
pyrethroid treated bednets is being trialed in Africa. Pyrethroid resistance is commonly 19 
associated with elevated levels of P450 expression including CYPs 6M2, 6P2, 6P3, 20 
6P4, 6P5, 6Z2 and 9J5. Having expressed these P450s in E. coli we find all are 21 
capable of metabolizing PPF. Inhibition of these P450s by permethrin, deltamethrin 22 
and PPF was also examined. Deltamethrin and permethrin were moderate inhibitors 23 
(IC50 1 – 10 M) of diethoxyfluorescein (DEF) activity for all P450s apart from CYP6Z2 24 
(IC50 >10 M), while PPF displayed weaker inhibition of all P450s (IC50 >10 M) except 25 
CYP’s 6Z2 and 6P2 (IC50 1 – 10 M). We found evidence of low levels of cross 26 
resistance between PPF and other insecticide classes by comparing the efficacy of 27 
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PPF in inhibiting metamorphosis and inducing female sterility in an insecticide 28 
susceptible strain of An. gambiae and a multiple resistant strain from Cote d’Ivoire.    29 
 30 
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1. Introduction 38 
Malaria control is reliant on the use of insecticides. The dramatic reductions in malaria 39 
cases in Africa that have occurred over the last 15 years have been largely attributed 40 
to methods targeting the adult mosquito, primarily via the use of long lasting 41 
insecticidal nets (LLINs) treated with pyrethroids and, to a lesser extent indoor residual 42 
spraying (IRS) with pyrethroids and DDT and, more recently, carbamates and 43 
organophosphates (Bhatt et al., 2015; Ranson and Lissenden, 2016).  Resistance to 44 
pyrethroids is now widespread in the major malaria vectors in Africa with resistance to 45 
other classes of public health insecticides also on the increase (Ranson and 46 
Lissenden, 2016). There is therefore an urgent need both for new insecticides to 47 
maintain the efficacy of these proven tools, and for new tools to reduce malaria 48 
transmission by the mosquito.  49 
 50 
Pyriproxyfen (PPF) is a juvenile hormone analogue that inhibits metamorphosis.  It has 51 
been used for several decades to protect against cotton pests (Carriere et al., 2012) 52 
and its extremely low toxicity to humans has also enabled applications in public health 53 
such as addition to water storage containers to control Aedes populations (Darriet and 54 
Corbel, 2006; Lee, 2001). As PPF is active in very low concentrations, the active 55 
3 
 
ingredient can be disseminated by the insect itself; this autodissemination route was 56 
shown to be effective at controlling Aedes populations in trials in Peru (Devine et al., 57 
2009). For malaria vectors, difficulties in identifying and treating the diverse breeding 58 
sites for malaria vectors have so far largely confined larviciding for malaria control to 59 
easy to reach urban areas but the possibility of using autodissemination strategies to 60 
distribute PPF to target Anopheles oviposition sites in rural areas is being explored. 61 
Currently, however, control of Anopheles mosquitoes is more commonly targeted at 62 
the adult stage, hence the impact of PPF on embryogenesis, shows the greatest 63 
promise for malaria control. Exposure to PPF effectively sterilizes female mosquitoes 64 
and has also been shown to reduce adult longevity (Ohashi et al., 2012; Ngufor et al., 65 
2014). Sumitomo Chemicals Ltd has developed a LLIN incorporating both permethrin 66 
and PPF. This Olyset Duo®, net has been shown to be effective in laboratory and 67 
experimental hut trials (Aiku et al., 2006; Ngufor et al., 2014; Ohashi et al., 2012; 68 
Tsunoda et al., 2013) and is currently being evaluated in a randomised control trial in 69 
Burkina Faso to compare the efficacy of this combination net with conventional Olyset 70 
nets (Tiono et al., 2015). 71 
 72 
However, concerns have been raised about the performance of Olyset Duo against 73 
pyrethroid resistant populations (Koffi et al., 2015). An experimental hut study of Olyset 74 
Duo carried out in an area where the Anopheles gambiae population has high levels 75 
of both target site and metabolic resistance to pyrethroids found no significant 76 
difference in the number of sterile mosquitoes in huts with Olyset Duo compared to 77 
control huts (Koffi et al., 2015). 78 
 79 
Resistance to PPF has been reported in other insects including the greenhouse 80 
whitefly Trialeurodes vaporiarium (Karatolos et al., 2012) and the sweet potato whitefly, 81 
Bemisia tabaci (Rami Horowitz et al., 2003). Although the mechanisms of resistance 82 
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have not been fully described, elevated levels of genes involved in insect P450 and 83 
GST activity appear to be involved.  84 
 85 
Several P450 enzymes have been implicated in the development of metabolic 86 
insecticide resistance in An. gambiae but a relatively small subset of this large enzyme 87 
family are consistently found up-regulated in pyrethroid resistant populations (David et 88 
al., 2013, Inhgam et al., 2015). This candidate list is predominated by three subfamilies 89 
of the CYP6 P450s: CYP6P, CYP6M and CYP6Z, but also includes CYP9J5 90 
(Hemingway et al., 2013; Toé et al., 2015) and the two CYP4G enzymes, CYP4G16 91 
and 17 (Jones et al, 2013; Toé et al., 2015). CYP6M2 and CYP6P3 are confirmed 92 
pyrethroid metabolisers but are also active against insecticides from other insect 93 
classes (Mitchell et al., 2012; Muller et al., 2008; Stevenson et al., 2011). In contrast 94 
the CYP4G enzymes do not have detectable activity against insecticides but instead 95 
are believed to confer resistance via reducing insecticide uptake (Balabanidou et al, in 96 
press).  97 
 98 
Here, we expressed the CYPs 6M2, 6P1, 6P2, 6P3, 6P4, 6P5, 6Z2 and 9J5 in 99 
Escherichia coli and assessed their ability to metabolize PPF. We also assessed the 100 
likelihood of cross resistance between PPF and other insecticide classes by comparing 101 
the efficacy of PPF in inhibiting metamorphosis and inducing female sterility in an 102 
insecticide susceptible strain of An. gambiae and a multiple resistant strain from Cote 103 
d’Ivoire. 104 
 105 
2. Material and methods 106 
2.1 Reagents 107 
Oligonucleotides were synthesized by Eurofins genomics and enzymes for DNA 108 
manipulation were supplied by Thermo Scientific. Isopropyl-ß-D-thio-109 
galactopyranoside (IPTG), 5-aminolevulinic acid (ALA), and 3-[(3-cholamidopropyl)-110 
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dimethylammonio]-1-propanesulfonate (CHAPS) were supplied by Melford (UK). 111 
Insecticides were supplied by ChemService: 3-phenoxybenzyl (1R,S)-cis,trans-3-(2,2-112 
dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (permethrin, mixture of isomers), 113 
(S)-α-cyano-3-phenoxybenzyl (1R,3R)-cis-2,2-dimethyl-3-(2,2-dibromovinyl)-114 
cyclopropanecarboxylate (deltamethrin) and pyriproxyfen. HPLC solvents were 115 
supplied by Fisher Scientific. Other chemicals were obtained from Sigma-Aldrich 116 
unless indicated otherwise.  117 
 118 
2.2 Gene cloning  119 
Total RNA was extracted with either the Arcturus PicoPure Kit (Applied Biosystems) 120 
or TRI reagent (Sigma-Aldrich) from ten adult An. gambiae mosquitoes from the 121 
Kisumu strain. Complementary DNA was prepared using Superscript III (Invitrogen) 122 
with an oligo(dT)20 primer and used as a template for amplifying full-length genes with 123 
KOD DNA polymerase (Merk Chemicals). The gene-specific primers used in these 124 
high-fidelity PCRs were designed according to the An. gambiae genome sequence 125 
(Table S1). PCR products from P450s, summarized in Table S2, were ligated into 126 
pGEM T-easy (Promega) and sequenced. For expression, the ompA leader sequence 127 
(ompA), was engineered onto the amino-terminus to direct the P450 to the E. coli outer 128 
membrane during expression as previously described (Mclaughlin et al., 2008; 129 
Stevenson et al., 2011). The ompA-leader was fused to the P450 cDNA in frame with 130 
the P450 initiation codon by fusion PCR. The ompA-leader was fused to the P450 131 
cDNA in frame with the P450 initiation codon by fusion PCR. The ompA P450 fusion 132 
was flanked at the 5’ and 3’ ends with NdeI and NotI respectively for ligation into 133 
NdeI/NotI digested pCWori+.   134 
 135 
For CYP6M2 and CYP6P3 a single plasmid expression system for the P450 and CPR 136 
was constructed by ligating the expression cassette (cDNA and tactac promotor) 137 
containing the An. gambiae NADPH P450 reductase (CPR) cDNA from the 138 
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pACYC:AgCPR plasmid described above into the pCW:P450 expression plasmid.  In 139 
the new construct the expression of each protein is under the control of its own tactac 140 
promoter so expression of both proteins is induced by the addition of IPTG to the 141 
culture. 142 
 143 
2.3 Preparation of membranes expressing P450 and AgCPR 144 
For dual plasmid co-expression of P450 and AgCPR (all P450s except CYP6M2 and 145 
CYP6P3), competent E. coli DH5α cells were co-transformed with pCW:P450 plasmid 146 
and pACYC:AgCPR (Stevenson et al., 2011). Cultures, generally 0.2 l, were 147 
supplemented with 1.0 mM ALA and incubated at 23oC for 18 – 24 hours after 1mM 148 
IPTG induction. P450 expression, E. coli membrane isolation and determination of 149 
P450 and AgCPR content was performed as previously described (Mclaughlin et al., 150 
2008; Stevenson et al., 2012). Samples were stored in aliquots at -80 °C. An. gambiae 151 
cytochrome b5 (b5) was prepared as described previously to supplement enzyme 152 
reactions at a 10:1 molar ratio, b5:P450 (Stevenson et al., 2011). 153 
 154 
For CYP6M2 and CYP6P3, E. coli JM109 were transformed with the single plasmid 155 
system for the co-expression of AgCPR. Cultures were grown in 10 l stirred batch, 156 
glass fermenters and were harvested and processed to produce membrane fractions 157 
containing the CYP and CPR using the procedures described above, scaled to account 158 
for the larger culture volumes. Cytochrome b5 was added to the CYP6P3 bacterial 159 
membrane preparations at a 10:1 molar ratio, b5:P450. After the addition of the 160 
cytochrome b5 the membrane preparation was gently stirred at 4°C for 30 min to allow 161 
time for the incorporation of the cytochrome b5 into the membranes before aliquotting 162 
and freezing at -80 °C. 163 
 164 
2.4 Pyriproxyfen metabolism  165 
7 
 
Incubations of a 200 µl reaction mix containing 20 µM insecticide, 0.1 µM of the 166 
recombinant enzyme, 1.0 µM b5, 0.2 M of TrisHCl at pH 7.4, 0.25 mM MgCl2, 1 mM 167 
glucose-6-phosphate, 0.1 mM NADP+ and 1 unit/mL glucose-6-phosphate 168 
dehydrogenase (G6PDH) were carried out in the presence or absence of 10 µM 169 
piperonyl butoxide (PBO) at 30°C with shaking (1200 rpm) for 90 min and stopped by 170 
addition of 200 µl of methanol. Shaking was carried for an additional 10 min before 171 
centrifuging the reactions at 20000 g for 20 min. 150 µl of supernatant was used for 172 
HPLC analysis. Reactions were performed in triplicate and a paired T-test of sample 173 
reactions (+NADPH) vs negative control (-NADPH) used for statistical measurements 174 
of substrate depletion.  175 
 176 
For reciprocal IC50 measurements of CYP6P3 metabolism of PPF and permethrin, 177 
enzyme reactions were carried out with PPF or permethrin added as inhibitors  (at 178 
concentrations ranging from of 0 - 1.6 mM or 0 -3.2 mM respectively) to the reaction 179 
mix to titer their effect on the insecticide turnover (fixed at 20 µM). Three replicates of 180 
positive and negative control reactions were run for each P450/inhibitor combination.  181 
 182 
2.5 High-pressure liquid chromatography (HPLC) analysis 183 
Samples were analyzed by high-pressure liquid chromatography, HPLC (Agilent 1100 184 
series). The quantity of insecticide remaining in the samples was determined by 185 
reverse-phase HPLC with a monitoring absorbance at 232 nm using a C18 column, 186 
Acclaim 120, Thermo Scientific. 100 µl of sample was loaded with a flow-rate 1 ml/min 187 
at 23 °C into an isocratic mobile phase 90% methanol and 10% water. The retention 188 
time for PPF is 7.4 min and for PBO 7.1 min.  189 
 190 
The same conditions were applied for HPLC analysis for the PPF/permethrin inhibition 191 
assays. Retention time for trans- and cis-permethrin is 11.8 min and 14.1 min 192 
respectively. 193 
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 194 
 195 
Mass spectrometry analysis for pyriproxyfen metabolism 196 
PPF metabolism by CYP6P3 was examined by mass spectrometry to confirm oxidation 197 
and identify the metabolites produced. Aliquots (5 µl) of organic solvent-quenched 198 
reaction supernatant were injected onto a high resolution Thermo Q-Exactive mass 199 
spectrometer (MS) that was coupled to a 1290 series Agilent LC system. The 200 
chromatographic separation was performed on a Waters Acquity BEH C18 (2.1 x 50 201 
mm; 1.7 µm) analytical column at 30 ºC using a mixture of water (0.1% formic acid) (A) 202 
and acetonitrile (0.1% formic acid) (B) as mobile phase. In the 12 minutes run time the 203 
gradient program was as follows: 5% B in 0-1 minute; 5% B to 100% B in 1-8 minutes; 204 
100% B in 8-10 minutes; 100% B to 5% B in 10-10.1 minutes; 5% B in 10.1-12 minutes. 205 
During the analysis the MS was operated in positive ion full scan mode (mass range: 206 
100-1000 m/z) at 35K resolution using a constant heated electrospray capillary 207 
temperature (320 ºC), spray voltage (3500 V), sheath gas (55 arbitrary units) and 208 
auxiliary gas flow rate (10 arbitrary units). 209 
 210 
2.6 Diethoxyfluorescein metabolism 211 
Diethoxyfluorescein (DEF) substrate was dissolved in DMSO, with final concentration 212 
of 2 % per assay. All test compounds were dissolved in DMSO, with a final solvent 213 
concentration <2 % per assay. For calculation of the kinetic parameters (KM and Vmax), 214 
each P450 was used at a final concentration of 10 nM (1 pmol/reaction) and DEF 215 
concentrations in the range: 0, 0.31, 0.63, 1.25, 2.5, 5, 10 and 20 µM. DEF reactions 216 
were carried out at 25 °C in 50 mM KPi at pH 7.4 containing 1 mM glucose-6-217 
phosphate (G6P), 0.1 mM NADP+, 0.25 mM MgCl2, and cytochrome b5 at a 10:1 molar 218 
ratio, b5:P450. NADP+ and G6P were excluded from the minus NADPH controls.  219 
 220 
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Variable ligand concentrations were used for IC50 calculations with DEF used at ~ KM 221 
for each P450 (i.e. 0.5, 1.4, 0.7, 1.0, 3.5 and 0.5 µM for CYP6M2, CYP6P2, CYP6P3, 222 
CYP6P4, CYP9J5, and CYP6Z2 respectively) and 0.1 µM P450. Three replicates of 223 
positive and negative control reactions were run for each P450/substrate combination 224 
in opaque white 96-well (flat-based) plates in triplicate. The fluorescent reactions were 225 
monitored in a fluorescence plate-reader (Ex = 485 nm, Em = 520 nm) continuously 226 
over 20 minutes time period after the addition of NADPH regenerating system. The 227 
rate of fluorescent molecules produced per P450 molecule per min (turnover) was 228 
determined by linear regression of the measurements between 3 min and 10 min after 229 
the reactions began. The Michaelis-Menten and IC50 fitting calculations were 230 
performed using Graphpad Prism 6. Data were fitted to the dose-response model and 231 
plots with R2 <0.95 were rejected. 232 
 233 
2.8 In vivo studies 234 
Two strains of mosquitoes were used to assess the impact of exposure to PPF on life 235 
history. The Kisumu strain of An. gambiae originates from Kenya  and is susceptible to 236 
all insecticide classes used in public health whereas the Tiassalé strain from Cote 237 
d'Ivoire  shows resistance to four classes (pyrethroids, carbamates, organophosphates 238 
and the organochlorine DDT) (Constant et al, 2012). Resistance in the Tiassalé strain 239 
is mediated by multiple mechanisms, including the overexpression of cytochrome 240 
P450s, notably CYP6P3, 6P4 and 6M2 (Constant et al, 2014). Both mosquito strains 241 
were reared in the insectaries at the Liverpool School of Tropical Medicine under a 242 
12:12 photoperiod at 27oC and 70-80% humidity. 243 
 244 
To measure the effect of PPF on metamorphosis, SumiLarv®0.5G (Sumitomo 245 
Chemicals Ltd) was ground into a fine powder and dissolved in water to prepare a 246 
stock solution of 1000 ppm SumiLarv (50 ppm active ingredient). The solution was left 247 
overnight dissolving on a magnetic stirrer, protected from light. Serial dilutions were 248 
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prepared and the following PPF concentrations were tested: 0.001 ppb, 0.005 ppb, 249 
0.07 ppb, 0.1 ppb, 1 ppb, 5 ppb and 10 ppb. Four replicates of 25 3rd instar mosquitoes 250 
were exposed to each of the SumiLarv concentrations in paper cups for up to 8 days. 251 
Larvae were fed Tetramin® baby fish food every day and cups covered with netting to 252 
prevent adults escaping. The number of live and dead larvae, pupae and adults was 253 
recorded every 24 hours until all individuals were emerged as adults or dead. Adults 254 
and dead pupae were removed daily. The Dose Effect function on XLSTAT (Microsoft) 255 
was used to estimate the concentration resulting in 50 % emergence inhibition (EI50). 256 
 257 
To compare the impact of PPF on adult mosquitoes of the two strains, we measured 258 
the ability of this compound to impair ovary development. Borosilicate glass tubes (30 259 
cm long, 11 mm wide) were impregnated with three different concentrations of PPF 260 
(ai): 0.55 mg/m2, 2.75 mg/m2 and 5.5 mg/m2. An additional tube impregnated only with 261 
the solvent (acetone) was used as a negative control. Tubes were used on the day of 262 
preparation. Two groups of fifteen 5-7 days old female mosquitoes from Tiassalé and 263 
Kisumu strains were tested for each concentration (n= 30). After 60 minutes 264 
acclimation in paper cups, they were transferred to the glass tubes and exposed for 3 265 
minutes. Mosquitoes were then returned to the paper cups and left for 24 hours with a 266 
10% sucrose solution. 24 hours after exposure the mosquitoes were bloodfed and any 267 
mosquitoes which did not feed were removed. Mosquitoes were retained in insectary 268 
conditions with access to sugar water for five days and then dissected and the 269 
morphology of the ovaries assessed as normal (loose, well developed eggs) or 270 
abnormal (non-detachable, bubble-like eggs). Dead mosquitoes or mosquitoes not 271 
presenting egg development were discarded and removed from the analysis. 272 
 273 
To confirm that formulated products containing PPF also impaired egg development, 274 
mosquitoes were exposed to Olyset Duo nets, nets containing 1 % PPF only (supplied 275 
by Sumitomo Chemicals Ltd), conventional Olyset nets or untreated nets. Batches of 276 
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10 3-5 days old Tiassalé mosquitoes were exposed to the nets for 3 minutes following 277 
WHO standard protocols for cone bioassays. Twenty-four hours after the exposure, 278 
mosquitoes were bloodfed and left in paper cups with 10% sucrose solution. Dead and 279 
non-bloodfed mosquitoes were removed from the experiment. After 5 days surviving 280 
mosquitoes were dissected and the morphology of the ovaries examined as described 281 
above. To assess the effects of short exposures to PPF LLINs, an additional set of 282 
cone bioassays was performed, as described above, except exposure time was 283 
reduced to 30 seconds.  284 
 285 
3. Results and Discussion 286 
This study was motivated by concerns over cross resistance between pyrethroid 287 
insecticides and the insect growth regulator, PPF. Cross resistance between 288 
insecticide classes with different modes of action, mediated by cytochrome P450s, has 289 
previously been demonstrated in An. gambiae (Constant et al., 2014; Mitchell et al., 290 
2012) and here we investigated whether these same P450 enzymes can also 291 
metabolize PPF. CYP6M2, CYP6P3 and CYP6Z2 have previously been expressed in 292 
bacterial expression systems but we extended the panel of recombinant enzymes to 293 
include a further three An. gambiae CYP6P P450s implicated in pyrethroid resistance 294 
in Cote d’Ivoire (Constant et al, 2014) and CYP9J5, which has been found over 295 
expressed in pyrethroid resistant populations from Bioko Island (Hemingway et al., 296 
2013) and Burkina Faso (Toé et al., 2015).  297 
 298 
3.1 Functional expression of P450s in E. coli 299 
P450s require electrons from NADPH-cytochrome P450 oxido-reductase (CPR) for 300 
catalysis, thus new candidate An. gambiae P450s were co-expressed with AgCPR in 301 
E. coli using ompA and pelB leader sequences to direct the enzymes to the inner 302 
bacterial membrane as previously with CYP6M2 and CYP6P3 (Muller et al., 2008; 303 
Stevenson et al., 2011). CYP’s 6P1, 6P2, 6P4, 6P5, 9J5 and 6M1 were co-transformed 304 
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with AgCPR-pACYC for E. coli expression, producing characteristic CO-reduced 305 
spectra indicative of active P450 (Fig. S1). The yields of P450 were in the range 10 – 306 
100 nmol/L, with CYP6P5 producing the lowest quantities of P450 (~ 10 nmol/L; Table 307 
S3). CYPs 6P1 and 6M1 failed to express functional P450. 308 
 309 
CYP6M2 and CYP6P3 have previously been expressed following co-transformation 310 
with AgCPR on separate plasmids. Here, these enzymes were co-expressed in 311 
tandem with AgCPR on a single from the P450 expression plasmid, pCWori+ to 312 
facilitate scaled 10 l fermentor expression. Tandem expression from the single plasmid 313 
produced higher CPR:P450 ratios. The fluorogenic substrate DEF was used to 314 
estimate the kinetic parameters of the tandemly expressed recombinant proteins 315 
against dual plasmid protein expression (Table 1) and used in dose-response 316 
experiments to determinate the inhibitory effect of permethrin, deltamethrin and 317 
pyriproxyfen in its metabolism. As expected, since CPR is rate limiting, the Vmax values 318 
were 3 - 6 fold higher using the single plasmid in tandemly expressed membranes 319 
compared with dual plasmid expression, consistent with the elevated levels of CPR. 320 
The KM value is the concentration of DEF required to reach max reaction velocity and 321 
independent of the enzyme concentration. The single versus double plasmid  KM 322 
values for CYP6M2 (0.4 vs 0.5 M)  and CYP6P3 (0.7 vs 0.9 M)  were similar, again 323 
consistent with higher CPR levels increasing reaction rates through enhanced electron 324 
transfer rather than effects on substrate binding.  325 
 326 
3.2 PPF metabolism 327 
The ability of the An. gambiae P450s to metabolize PPF was tested by measuring 328 
substrate turnover (substrate disappearance over time) in the presence and absence 329 
of NADPH. We also included PBO in parallel reactions as further validation of P450 330 
induced substrate depletion (Fig. S2). PBO is an inhibitor of P450 monoxygenase 331 
activity and a common insecticide synergist (Vijayan et al., 2007). All seven P450s 332 
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metabolized PPF to some degree with the percentage PPF depletion ranging from 333 
24.78 % for CYP9J5 to 100% for CYP6P3, and PPF depletion was inhibited by PBO 334 
for each P450 tested (Table 2).  Since E. coli membranes expressing CYP6M2 and 335 
CYP6P3 had higher levels of CPR, the rates of activity were not comparable with the 336 
rest of the P450s. However, it is notable that, with the exception of CYP6P5, all 337 
members of the CYP6P family and CYP6Z2 produced high levels of PPF depletion (58 338 
- 100%). CYP6Z2 is of interest since it is found overexpressed in pyrethroid resistant 339 
populations of An. gambiae, but metabolises the pyrethroid metabolites 3-340 
phenoxbenzoic alcohol and aldehyde rather than the parent compound (Chandor-341 
Proust et al., 2013). Here CYP6Z2 appears to play a direct role in the primary 342 
metabolism of PPF, thus may have an influential role in PPF clearance and potentially 343 
insecticide resistance. 344 
 345 
Mass spectrometry analysis of the PPF metabolites generated by CYP6P3, the 346 
strongest metabolizer was carried out to confirm oxidation and identify possible 347 
metabolites. Expected metabolites included 4`-OH-PPF, 5``-OH- PPF and 5``,4`-OH-348 
PPF, that have been previously identified from the in vitro metabolism of PPF by 349 
microsomes from housefly larvae (Zhang et al., 1998). CYP6P3 generated three 350 
metabolite peaks (Fig. S3). The extracted ion chromatograms of [M+H]+ generated two 351 
peaks (6.9 min and 7.1 min), with molecular mass (m/z=338.1387) corresponding to 352 
the addition of a hydroxyl group (m/z=16), consistent with  4`-OH-pyriproxyfen and 5``-353 
OH-pyriproxyfen production. Furthermore, the data showed signs of a metabolite with 354 
molecular mass 32 m/z larger than PPF, equivalent to a double hydroxylation, 355 
potentially 5``,4`-OH-PPF resulting from secondary metabolism of 5’’-OH-PPF and/or 356 
4`-OH-PPF metabolites. This was, however, not confirmed chromatographically as 357 
analytical reference standards were not available for the analysis.  Further collision 358 
mass spectrometry or NMR is required to confirm the identity of the metabolites.  359 
 360 
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Since PPF is being used in combination with pyrethroids in bednets we were interested 361 
in potential synergistic effects. We therefore measured the IC50 values of PPF, 362 
deltamethrin and permethrin to compare relative strengths of DEF metabolism 363 
inhibition against the P450s (Table 3). The fluorescent substrate, DEF, was used for 364 
monitoring P450 activity using a 96 well microtiter plate format. In drug screens, 365 
compounds are generally categorized according to their activity as P450 inhibitors as 366 
potent inhibitors (IC50 <1 M), moderate (IC50 1 – 10 M) and weak inhibitors (IC50 > 367 
10 M) (Krippendorff et al., 2007). Using these criteria, PPF displayed moderate 368 
inhibition of DEF metabolism for CYP’s 6Z2 and 6P2, with the remainder being weakly 369 
inhibited. Deltamethrin and permethrin were moderate inhibitors of DEF activity for all 370 
P450s apart from CYP6Z2, which was weakly inhibited by both pyrethroids. As Olyset 371 
Duo nets contain both PPF and permethrin, we also measured PPF inhibition of 372 
permethrin metabolism by CYP6P3 and vice versa (Fig. 1). CYP6P3 was chosen as it 373 
is one of the P450s most frequently found at elevated levels of expression in pyrethroid 374 
resistant populations of An. gambiae. Permethrin produced slightly stronger inhibition 375 
of PPF metabolism (IC50 = 61.2 M) than PPF inhibition of permethrin metabolism  376 
(IC50 = 92.7 M). Overall, the in vitro results suggest that the pyrethroids deltamethrin 377 
and permethrin are slightly stronger inhibitors  (2 – 3 fold) than PPF against the 378 
pyrethroid metabolizing P450s tested.  379 
 380 
These data indicate that PPF can be metabolized by a wide range of P450s associated 381 
with pyrethroid resistance. In mosquitoes that have elevated levels of expression of 382 
one or more of these enzymes, it is feasible that enhanced metabolism of PPF could 383 
reduce the efficacy of this juvenile hormone analogue. To test this hypothesis we 384 
performed PPF bioassays on insecticide susceptible and resistant strains. 385 
 386 
3.3 Bioefficacy of PPF against insecticide resistant mosquitoes 387 
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The impact of exposure to PPF on metamorphosis and embryogenesis was compared 388 
in the insecticide susceptible Kisumu strain and the multi resistant Tiassalé strain from 389 
Cote d’Ivoire.  The dose-response tests showed that SumiLarv® 0.5G affected adult 390 
mosquito emergence in both strains but the minimum dose that inhibited 100 % 391 
emergence was 1 ppb in the insecticide susceptible Kisumu strain and 10 ppb in the 392 
Tiassalé strain. The concentration that resulted in 50 % inhibition of emergence (EI50) 393 
for the susceptible Kisumu strain was 0.088 ppb (95 % confidence intervals 0.064 – 394 
0.123 ppb) (Fig. 2), similar to values reported for An. gambiae s.l. in other studies 395 
(0.025 ppb Kawada (1993), 0.13 ppb (Mbare et al 2013)). In contrast, the EI50 for the 396 
Tiassalé strain was 0.356 ppb ai (0.274 – 0.463) approximately 4-fold higher than the 397 
Kisumu strain. It is important to note that we cannot directly link the higher EI50 for 398 
PPF to the presence of elevated P450s in the Tiassale strain given that  only one 399 
pyrethroid resistant population was evaluated and it is not known whether the same 400 
P450s found elevated in adults of this strain are also up-regulated at the larval 401 
stage.   Furthermore, the field dose of SumiLarv 0.5G ranges from 10 - 50 ppb so it is 402 
likely that the product would still inhibit development of the Tiassalé strain under field 403 
conditions. However, given the trajectory of increasing pyrethroid resistance in both 404 
Anopheles (Ranson and Lissenden, 2016)  and Aedes mosquitoes (Vontas et al, 2012) 405 
and the growing interest in use of PPF to target immature populations of these vectors 406 
(Kiware et al, 2015, Abad-Franch et al., 2015;) it is important that further evaluation of 407 
PPF efficacy against field populations is carried out.  408 
 409 
As the sterilizing effect of PPF on mosquito populations has also received considerable 410 
attention for malaria control, with clinical trials of the PPF/permethrin Olyset Duo LLIN 411 
ongoing (Tiono et al, 2015, Sagnon et al., 2015)  we also compared inhibition of 412 
embryogenesis in our susceptible and resistant populations. In a narrow bore glass 413 
tube assay, designed to ensure complete contact with the PPF for the duration of the 414 
assay, mosquitoes from the insecticide susceptible Kisumu strain were completely 415 
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sterilized after a 3 minute exposure to 5.5 mg/m2 whereas only 75% of Tiassalé 416 
mosquitoes were sterilized by this dose. At half this dose, PPF had no impact on ovary 417 
development in Tiassalé but resulted in 76 % of Kisumu mosquitoes being sterilized 418 
(Fig. 3). Thus higher concentrations of PPF are needed to sterilize the pyrethroid 419 
resistant strain, consistent with the effect on metamorphosis described above. 420 
 421 
3.4 Interactions between PPF and Permethrin. 422 
The in vitro analysis demonstrated that the same P450s can bind and metabolize PPF 423 
and pyrethroids. This interaction could have a synergizing effect with one chemical 424 
essentially reducing the rate of depletion of the other such that both chemicals are 425 
more potent when used in combination.  As the pyrethroid IC50s were generally lower 426 
than for PPF (with the exception of CYP6Z2), pyrethroids might be expected to have 427 
a stronger enhancing effect on PPF activity than vice versa.  However, the differences 428 
in IC50 values were small (~2 fold) and, as the in vivo concentrations in mosquitoes 429 
after exposure to products containing PPF and/or permethrin are unknown, such 430 
predictions in isolation are highly speculative.  Furthermore, as shown above, the 431 
performance of PPF varies between strains and thus the impact of combining the two 432 
chemistries in vector control products may depend on the level of expression of P450s 433 
in the strain.  434 
 435 
To investigate this further we evaluated the performance of LLINs containing a single 436 
active ingredient versus the combination Olyset Duo LLIN in cone bioassays. The 437 
Tiassalé strain was exposed to four net types, mortality recorded 24 hours after 438 
exposure and surviving mosquitoes were offered a bloodmeal. Ovary development 439 
was assessed after a further 5 days. As expected very low mortality was observed in 440 
the mosquitoes exposed to untreated or PPF only nets (Table 4). Mortality was higher 441 
after exposure to Olyset Duo nets than conventional Olyset nets (2-tailed z test, 442 
p=0.02). All bloodfed mosquitoes exposed to the Olyset or untreated nets developed 443 
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normal ovaries. In contrast all of the mosquitoes exposed to the 1% PPF net were 444 
sterilized. The number of surviving mosquitoes that successfully bloodfed from the 445 
Olyset Duo arm was small but surprisingly only 60 % of these mosquitoes were 446 
sterilized. The differential sterilizing effect of nets containing 1 % w/w PPF alone and 447 
Olyset Duo (with 1% PPF and 2 % permethrin) was confirmed in follow up cone 448 
bioassay study in which mosquitoes were only exposed for 30 seconds. Here > 87 % 449 
of Tiassalé mosquitoes exposed to PPF nets (n=34 dissections) were sterilized versus 450 
0% for untreated nets (n=39) and only 16 % for Olyset Duo nets (n= 38) (Table S4).  451 
 452 
Taken together these results suggest that PPF increases the efficacy of permethrin 453 
but permethrin reduces the efficacy of PPF. This is supported by data showing higher 454 
mortality rates in huts with Olyset Duo than with Olyset in areas with resistant 455 
mosquitoes (Ngfour et al 2014 in Benin, Koffi et al, 2015 in Cote d’Ivoire) (although no 456 
increase in the proportion of mosquitoes sterilised in huts containing PPF only nets 457 
versus Olyset Duo nets was observed, as our laboratory data would have predicted).  458 
It is important to note that these experiments are conducted on formulated products, 459 
and although the concentration of permethrin and PPF does not differ between net 460 
types, they may differ in their bleed rates affecting the bioavailability of the two active 461 
ingredients.  Further laboratory and field evaluations, against vectors with differing 462 
levels of metabolic resistance, are needed to better predict the performance of 463 
combination products, such as Olyset Duo, in the field. 464 
 465 
Conclusions 466 
Given that pyrethroid resistant populations of malaria vectors are now ubiquitous in 467 
Africa, it is important to evaluate the possible impact of this resistance on the 468 
performance of any new vector control tools.  In this study we demonstrated that a 469 
subset of mosquito P450 enzymes responsible for elevated pyrethroid metabolism in 470 
insecticide resistant mosquitoes can also metabolize PPF. As metabolic resistance is 471 
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an increasingly problematic resistance mechanism in African malaria vectors, there is 472 
a very real concern that PPF resistance may already be present in field population of 473 
Anopheles mosquitoes.  Although the levels of PPF resistance we observed in the 474 
current study are low, continual monitoring for resistance to this chemistry should be 475 
undertaken in any area employing PPF as a larvicide or considering PPF use for adult 476 
mosquito control. 477 
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Figure captions 620 
 621 
Figure 1. Determination of IC50 values of permethrin and PPF in P450 622 
metabolism. Dose-response analysis of the inhibitory effect of (A) pyriproxyfen on 623 
permethrin metabolism and (B) permethrin on pyriproxyfen metabolism.  624 
 625 
Figure 2. SumiLarv emergence inhibition curves for two strains of An. gambiae. 626 
Emergence inhibition dose response curves for the insecticide susceptible Kisumu 627 
strain (continuous line) and insecticide resistant Tiassalé strain (dotted line).  The grey 628 
dotted lines represent 95 % upper and lower limits.  629 
 630 
Figure 3. Effect of pyriproxyfen on egg development for two strains of An. 631 
gambiae. Proportions of normal/abnormal ovaries of mosquitoes from Tiassale and 632 
Kisumu strains exposed to three different concentrations of pyriproxyfen. The number 633 
over each bar corresponds to the sample size for each treatment. 634 
 635 
636 
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Table 1. Kinetic parameters for DEF  637 
 Kinetic parameters for DEF 
P450 
Single plasmid expression Dual plasmid expression 
KM (μM) Vmax (RFU/sec) KM (μM) Vmax (RFU/sec) 
       
CYP6M2 0.4 ± 0.02 902.2 ± 106.99 0.5 ± 0.01 292.5 ± 38.05 
CYP6P3 0.7 ± 0.10   54.4 ± 6.52 0.9 ± 0.09 14.8 ± 4.89 
CYP6P2          nt          nt 1.4 ± 0.02 300.6 ± 12.00 
CYP6P4          nt          nt 1.0 ± 0.04 24.2 ± 1.26 
CYP9J5          nt          nt 3.4 ± 0.21 265.1 ± 28.75 
CYP6Z2          nt          nt    0.5 ± 0.3    43.7 ± 8.9 
     
nt = not tested ; (mean ± SD) 
 638 
 639 
Table 2. Pyriproxyfen metabolism by mosquito P450s. 640 
P450  
% PPF depletion 
Inhibition ratio (%)a 
- PBO + PBO 
     
CYP6M2 30.93 ± 4.65 1.44 ± 0.67 95.3 
CYP6P2 58.03 ± 1.35 6.45 ± 3.22 91.0 
CYP6P3 100.0 ± 0.01 8.68 ± 1.74 91.3 
CYP6P4 81.63 ± 0.63 4.44 ± 1.99 94.6 
CYP6P5 39.96 ± 1.04 2.40 ± 2.01 95.4 
CYP9J5 24.78 ± 2.13 0.08 ± 0.15 99.6 
CYP6Z2 66.26 ± 3.02 8.41 ± 1.58 87.3 
       
a reduction of PPF depletion in percentage caused by the inhibitory effect of PBO; (mean ± SD)  
 641 
 642 
 643 
 644 
 645 
 646 
 647 
 648 
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Table 3. IC
50
 values for mosquito P450s. 649 
 650 
 651 
 652 
 653 
 654 
 655 
 656 
 657 
 658 
Table 4. Impact of exposure to LLINs containing permethrin and/or pyripoxyfen 659 
on mosquito mortality and egg development. An. gambiae Tiassalé strain were 660 
exposed to the LLINs for 3 min.  Mortality was measured 24 hours later and surviving 661 
mosquitoes offered a blood meal. Ovary dissections were performed 5 days later. n 662 
bloodfed accounts for the number of surviving mosquitoes that fed on blood and 663 
survived for five days until ovary dissections. 664 
 665 
 666 
 667 
 668 
 669 
  670 
 IC50 (μM) 
P450 Pyriproxyfen Deltamethrin Permethrin 
    
CYP6M2 14.14 4.24 8.07 
CYP6Z2 2.23 13.99 13.72 
CYP6P2 9.95 4.97 8.61 
CYP6P3 15.82 3.17 6.77 
CYP9J5 18.96 6.05 6.47 
    
LLIN n 
Mortality % 
(95%CI) 
n bloodfed Abnormal % Sterilised 
      
Untreated 45 
2.22 
(0.12-13.2) 
23 0 0 
Olyset 46 
30.4 
(18.2-45.9) 
19 0 0 
Olyset Duo 46 
54.3 
(39.2-68.8) 
10 6 60 
PPF 46 
2.17 
(0.11-13.0) 
35 35 100 
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 671 
 672 
Figure 1. Determination of IC50 values of permethrin and PPF in P450 673 
metabolism. Dose-response analysis of the inhibitory effect of (A) pyriproxyfen on 674 
permethrin metabolism and (B) permethrin on pyriproxyfen metabolism.  675 
  676 
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 677 
 678 
 679 
Figure 2. SumiLarv emergence inhibition curves for two strains of An. gambiae. 680 
Emergence inhibition dose response curves for the insecticide susceptible Kisumu 681 
strain (continuous line) and insecticide resistant Tiassalé strain (dotted line).  The grey 682 
dotted lines represent 95 % upper and lower limits.  683 
  684 
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 685 
 686 
Figure 3. Effect of pyriproxyfen on egg development for two strains of An. 687 
gambiae. Proportions of normal/abnormal ovaries of mosquitoes from Tiassale and 688 
Kisumu strains exposed to three different concentrations of pyriproxyfen. The number 689 
over each bar corresponds to the sample size for each treatment. 690 
 691 
 692 
 693 
  694 
30 
 
 695 
Table S1. Oligonucleotide sequences used for cloning An. gambiae P450 696 
genes. 697 
 698 
 699 
  700 
Target Orientation Sequence, 5' to 3' 
 
ompA F GGAATTCCATATGAAAAAGACAGCTATCGCG 
CYP6P1 R (L) CCGAGCAGTGACATCGGGACGGCCTGCGCTACGGTAGCGAA 
CYP6P1 R ATAAGAATGCGGCCGCTCACACCTGCACGATGCGC 
CYP6P2 R (L) GGTCAAGAGCTCCATCGGGACGGCCTGCGCTACGGTAGCGAA 
CYP6P2 R ATAAGAATGCGGCCGCTCAAAGCTTCTCCACCTCCAG 
CYP6P4 R (L) GCTTAACAGATCCATCGGGACGGCCTGCGCTACGGTAGCGAA 
CYP6P4 R ATAAGAATGCGGCCGCCTATATCTTATCAACCTTCAG 
CYP6P5 R (L) CGTAACGGGCTCCATCGGGACGGCCTGCGCTACGGTAGCGAA 
CYP6P5 R ATAAGAATGCGGCCGCCTACGCAATCTTATCCACCTTCAGG 
CYP9J5 R (L) TCAAACTGATCTCCATCGGGACGGCCTGCGCTACGGTAGCGAA 
CYP9J5 R ATAAGAATGCGGCCGCTCAGTTAGCAGCTTGCTTGC 
CYP6M1 R (L) GGTTGGGAACCACATCGGGACGGCCTGCGCTACGGTAGCGAA 
CYP6M1 R ATAAGAATGCGGCCGCTCAACCTTGCTTCGATTCAG 
 
R (L): reverse "linker" primer complementary to the first 21 bases of the P450 cDNA joined to the last bases of ompA 
sequence 
NdeI (CATATG) and NotI (GCGGCCGC) restiction sites highligthed in bold  
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Table S2. Accession numbers for P450 clones  701 
 702 
Gene  Reference* Single nucleotide polymorphism** 
    
CYP6P1 AY028785    1 synonymous, 0 missense 
CYP6P2 XM_312047 (AGAP002869)   2 synonymous, 1 missense c.241 G>A; V81I 
CYP6P4 XM_312048 (AGAP002867)   0 synonymous, 0 missense 
CYP6P5 XM_312049 (AGAP002866) 
 22 synonymous, 1 missense c.1369 C>T; 
R457W 
CYP9J5 XM_551896 (AGAP012296)    1 synonymous, 0 missense 
CYP6M1 AY062208.1 
 
23 synonymous, 8 missense  
 
c.103 G>A V35I 
c.232 A>C M78L 
c.640 G>A V214M 
c.645 A>C E215D 
c.720 T>G F240L 
c.1041 C>G D347E 
c.1201 T>G S401A 
c.1264 G>C A422P 
 
   
*Genebank accession code for complete cds, in brackets vectorbase code   ** Polymorphisms detected in our individuals 
 703 
 704 
  705 
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Table S3. P450 yields and CPR activity. 706 
 707 
P450  Na 
Expression Membrane content 
(nmol/L)b nmol P450/mgc nmol cyt c/min/mgd 
     
CYP6M2 
(1) 
1 nt 0.054 65 
CYP6P3 
(1) 
1 nt 0.067 620 
CYP6M2 
(2) 
1 nt 0.606 57 
CY6P3 (2) 2 38.8 ± 3.2 0.18 ± 0.02 188.5 ± 51.0 
CYP6P2 4 23.1 ± 1.9 0.21 ± 0.02 232.3 ± 76.1 
CYP6P4 6 67.9 ± 15.3 0.61 ± 0.14 258.1 ± 100.4 
CYP6P5 6 10.7 ± 3.1 0.10 ± 0.02 165.1 ± 71.9 
CYP9J5 4 26.0 ± 7.5 0.25 ± 0.07 281.3 ± 113.2 
CYP6Z2 2 122.4 ± 24.5 0.92 ± 0.02 245.4 ± 33.4 
          
a Number of independent membranes used for yield calculations.   
b nmol of P450 isolated membrane preparation per litre of bacterial cultures; nt, not tested 
c P450 concentration in membrane preparation as nmol of P450 per mg of total protein. 
d CPR activity in membrane preparation measured as nmol of cytochrome c reduced per min per mg of total protein 
Measurements are expressed as means ± standard deviation. 
(1) single plasmid, (2) double plasmid 
 708 
 709 
 710 
 711 
 712 
 713 
  714 
33 
 
 715 
Table S4 Mortality and sterilisation cause by a short-time exposure  to two 716 
type of LLINs on Tiassale An. gambiae mosquitoes. Mortality and 717 
sterilisation on Tiassale multi-resistant mosquitoes after 30 sec exposure to two 718 
different types of LLINs containing PPF. n bloodfed accounts for the number of 719 
surviving mosquitoes that fed on blood and survived for five days until ovary 720 
dissections. 721 
 722 
 723 
 724 
 725 
LLIN n 
Mortality % 
(95%CI) 
n bloodfed Abnormal % Sterilised 
      
Untreated 39 
2.56 
(0.13-15.1) 
38 0 0 
PPF 31 
22.6 
(10.3-41.5) 
24 21 87.5 
Olyset Duo 38 
15.8 
(6.59-31.9) 
38 6 15.8 
      
